|
⚲
|
| Keyboard |
| Harrell David
✚
|
|
|---|---|
| CIK # | 0001466061 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001466061] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| OptimizeRx Corp | |
| Harrell David |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
OptimizeRx Corp OPRX
Common Stock
|
2017-06-01 | Disposed to issuer | 500,000 | $0.78 | 390,000 |
|
OptimizeRx Corp OPRX
Common Stock
|
2015-06-24 | Grant | 79,042 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2014-05-01 | Grant | 100,000 | $0.00 | |
|
OptimizeRx Corp OPRX
Common Stock
|
2014-04-24 | Sell | 552,500 | $1.60 | 884,000 |
|
OptimizeRx Corp OPRX
Stock Options · derivative
|
2014-04-24 | Sell | 55,650 | $1.00 | 55,650 |
|
OptimizeRx Corp OPRX
Common Stock
|
2014-03-28 | Grant | 60,938 | $0.00 |